RIGEL PHARMACEUTICALS, INC. Employee Count
The employee counts RIGEL PHARMACEUTICALS, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2020-12-31: Employees (as filed) 169; Filing 2021-03-02; Lease expense per employee $37,195.27.
- 2019-12-31: Employees (as filed) 163; Filing 2020-02-27; Lease expense per employee $36,766.87.
- 2018-12-31: Employees (as filed) 158; Filing 2019-02-28; Lease expense per employee $37,974.68.
- 2017-12-31: Employees (as filed) 103; Filing 2018-03-06; Lease expense per employee $66,990.29.
- Available history
- 2008-12-31 to 2020-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2020-12-31 | 169 full-time | 2021-03-02 | $37,195.27 total lease cost |
| 2019-12-31 | 163 full-time | 2020-02-27 | $36,766.87 total lease cost |
| 2018-12-31 | 158 | 2019-02-28 | $37,974.68 rent expense, net |
| 2017-12-31 | 103 | 2018-03-06 | $66,990.29 rent expense, net |
| 2014-12-31 | 127 | 2015-03-03 | $118,897.64 rent expense, net |
| 2013-12-31 | 129 | 2014-03-04 | $114,728.68 rent expense, net |
| 2012-12-31 | 157 | 2013-03-05 | $93,630.57 rent expense, net |
| 2011-12-31 | 153 | 2012-03-06 | $96,732.03 rent expense, net |
| 2010-12-31 | 145 | 2011-03-01 | $104,827.59 rent expense, net |
| 2009-12-31 | 142 | 2010-03-02 | |
| 2008-12-31 | 181 | 2009-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |